ABRILADA Trademark

Trademark Overview

On Friday, May 8, 2020, a trademark application was filed for ABRILADA with the United States Patent and Trademark Office. The USPTO has given the ABRILADA trademark a serial number of 88907943. The federal status of this trademark filing is REGISTERED as of Tuesday, November 28, 2023. This trademark is owned by Pfizer Inc.. The ABRILADA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis

General Information

Serial Number88907943
Word MarkABRILADA
Filing DateFriday, May 8, 2020
Status700 - REGISTERED
Status DateTuesday, November 28, 2023
Registration Number7231118
Registration DateTuesday, November 28, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 15, 2020

Trademark Statements

Description of MarkThe mark consists of the following: An orange vertical bar on the left of the literal element "ABRILADA" depicted in the color black.
Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis
Indication of Colors claimedThe color(s) orange and black is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 21, 2020
Primary Code005
First Use Anywhere DateWednesday, October 18, 2023
First Use In Commerce DateWednesday, October 18, 2023

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10548

Trademark Events

Event DateEvent Description
Tuesday, May 12, 2020NEW APPLICATION ENTERED
Thursday, May 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 22, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, July 29, 2020ASSIGNED TO EXAMINER
Friday, July 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 3, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 3, 2020WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Friday, August 7, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, August 7, 2020EXAMINERS AMENDMENT E-MAILED
Friday, August 7, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 7, 2020ASSIGNED TO LIE
Saturday, August 8, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, August 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 15, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 17, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021SOU EXTENSION 1 FILED
Wednesday, March 17, 2021SOU EXTENSION 1 GRANTED
Friday, March 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 11, 2021SOU TEAS EXTENSION RECEIVED
Monday, October 11, 2021SOU EXTENSION 2 FILED
Monday, October 11, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 22, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 22, 2022SOU EXTENSION 3 FILED
Friday, April 22, 2022SOU EXTENSION 3 GRANTED
Monday, October 17, 2022SOU EXTENSION 4 FILED
Tuesday, April 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 17, 2022SOU EXTENSION 4 GRANTED
Wednesday, October 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 5 FILED
Thursday, April 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 20, 2023SOU EXTENSION 5 GRANTED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2023USE AMENDMENT FILED
Wednesday, October 18, 2023TEAS STATEMENT OF USE RECEIVED
Monday, October 23, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 25, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 26, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 28, 2023REGISTERED-PRINCIPAL REGISTER

Related Keywords

abrilada pharmaceutical disorders treatment preparations skin arthritis inflammatory autoimmune diseases